• Latest Posts
In Depth 28 Sep 2023

Obesity drug success sparks biotech buying spree

Aspect and Novo Nordisk working on bioprinted tissue for diabetes and obesity

Debiopharm adds to oncology pipeline


Heartseed and Novo Nordisk dose first patient in heart failure cell therapy study

Is Copenhagen the world capital of life science?

FDA clears insulin pen medical device

More News! 23 Nov 2022

Novo Nordisk announces $750M facility expansion

More News! 10 Nov 2022

Novo Nordisk supports Plant2Food platform with €27M funding

ASPIRE set up to collaborate on amyloidosis